Neuronetics, Inc. (STIM)
- Previous Close
2.0300 - Open
2.1200 - Bid 2.1800 x 100
- Ask 2.2700 x 100
- Day's Range
2.1100 - 2.2800 - 52 Week Range
1.0300 - 5.0700 - Volume
167,586 - Avg. Volume
162,379 - Market Cap (intraday)
67.195M - Beta (5Y Monthly) 2.32
- PE Ratio (TTM)
-- - EPS (TTM)
-0.9400 - Earnings Date Aug 6, 2024 - Aug 12, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
7.00
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
neurostar.com202
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: STIM
Performance Overview: STIM
Trailing total returns as of 6/7/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: STIM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: STIM
Valuation Measures
Market Cap
67.19M
Enterprise Value
81.12M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.89
Price/Book (mrq)
2.43
Enterprise Value/Revenue
1.11
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-37.61%
Return on Assets (ttm)
-15.37%
Return on Equity (ttm)
-72.48%
Revenue (ttm)
73.22M
Net Income Avi to Common (ttm)
-27.54M
Diluted EPS (ttm)
-0.9400
Balance Sheet and Cash Flow
Total Cash (mrq)
47.73M
Total Debt/Equity (mrq)
225.90%
Levered Free Cash Flow (ttm)
-22.42M
Research Analysis: STIM
Company Insights: STIM
STIM does not have Company Insights